Published online Jun 14, 2019. doi: 10.3748/wjg.v25.i22.2699
Peer-review started: February 22, 2019
First decision: March 27, 2019
Revised: April 4, 2019
Accepted: April 19, 2019
Article in press: April 20, 2019
Published online: June 14, 2019
Processing time: 113 Days and 15.6 Hours
The exocrine structure is significantly affected by diabetes because of endocrine structure-function disorder within the pancreas. Exocrine pancreatic dysfunction (EPD) is the general name of the malabsorption process resulting from inadequate production, release, decreased activation, and/or insufficient degradation of enzymes required for digestion from pancreatic acinar cells. It is important to diagnose patients early and correctly, since there may be both macro- and micro-nutrient deficiency in EPD. In this paper, EPD, the diabetes-EPD relationship, and the predictive, effective factors affecting the emergence of EPD are briefly explained and summarized with contemporary literature and our experienced based on clinical, lab, and radiological findings.
Core tip: The early diagnosis of exocrine pancreatic dysfunction cases and initiation of treatment in diabetic patients are important. From this point of view, it is also important to obtain clinical signs and to apply clinical practice to the diagnosis of mild to moderate cases. Direct or indirect exocrine pancreatic dysfunction testing for all diabetic patients is not cost-effective. In this context, we must determine which diabetic patients should be tested.